Stock listing

AXD2 Stock Price, News, Filings & Events — Heron Therapeutics, Inc.

Selected listing: AXD2 · TRADEGATE · EUR · DE

The AXD2:TRADEGATE listing represents Heron Therapeutics, Inc., a biopharmaceutical company focused on developing innovative therapies for patients with unmet medical needs. Recently, the company has been involved in advancing its product pipeline and has made filings related to its ongoing clinical trials. Investors can stay updated on Heron's latest news and events, which may impact its market performance and strategic direction. The company operates in a competitive landscape, emphasizing the importance of its research and development efforts.

AXD2:TRADEGATEEURDEUpdated July 24, 2026
Heron Therapeutics, Inc. logo
Ticker
AXD2:TRADEGATE
Asset type
Stock
Market cap
$86.3M
Sector
Health Technology
Industry
Biotechnology
Exchange
TRADEGATE
Currency
EUR

Heron Therapeutics, Inc. AXD2:TRADEGATE stock context

The AXD2:TRADEGATE listing represents Heron Therapeutics, Inc., a biopharmaceutical company focused on developing innovative therapies for patients with unmet medical needs. Recently, the company has been involved in advancing its product pipeline and has made filings related to its ongoing clinical trials. Investors can stay updated on Heron's latest news and events, which may impact its market performance and strategic direction. The company operates in a competitive landscape, emphasizing the importance of its research and development efforts.

Research Heron Therapeutics, Inc.

Alternate listings